Your browser doesn't support javascript.
loading
Characteristics of 1555 childhood-onset lupus in three groups based on distinct time intervals to disease diagnosis: a Brazilian multicenter study.
Novak, G V; Molinari, B C; Ferreira, J C; Sakamoto, A P; Terreri, M T; Pereira, R M R; Saad-Magalhães, C; Aikawa, N E; Campos, L M; Len, C A; Appenzeller, S; Ferriani, V P; Silva, M F; Oliveira, S K; Islabão, A G; Sztajnbok, F R; Paim, L B; Barbosa, C M; Santos, M C; Bica, B E; Sena, E G; Moraes, A J; Rolim, A M; Spelling, P F; Scheibel, I M; Cavalcanti, A S; Matos, E N; Robazzi, T C; Guimarães, L J; Santos, F P; Silva, C T; Bonfá, E; Silva, C A.
Affiliation
  • Novak GV; 1 Pediatric Rheumatology Unit, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Molinari BC; 1 Pediatric Rheumatology Unit, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Ferreira JC; 1 Pediatric Rheumatology Unit, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Sakamoto AP; 2 Pediatric Rheumatology Unit, Universidade Federal de Sao Paulo, Sao Paulo, Brazil.
  • Terreri MT; 2 Pediatric Rheumatology Unit, Universidade Federal de Sao Paulo, Sao Paulo, Brazil.
  • Pereira RMR; 3 Division of Rheumatology, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Saad-Magalhães C; 4 Pediatric Rheumatology Division, Sao Paulo State University (UNESP), Botucatu, Brazil.
  • Aikawa NE; 1 Pediatric Rheumatology Unit, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Campos LM; 3 Division of Rheumatology, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Len CA; 1 Pediatric Rheumatology Unit, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Appenzeller S; 2 Pediatric Rheumatology Unit, Universidade Federal de Sao Paulo, Sao Paulo, Brazil.
  • Ferriani VP; 5 Pediatric Rheumatology Unit, University of Campinas (UNICAMP), Campinas, Brazil.
  • Silva MF; 6 Pediatric Rheumatology Unit, University of Sao Paulo, Ribeirão Preto, Brazil.
  • Oliveira SK; 7 Pediatric Rheumatology Unit, Hospital Geral de Fortaleza, Fortaleza, Brazil.
  • Islabão AG; 8 Pediatric Rheumatology Unit, Rio de Janeiro Federal University (IPPMG-UFRJ), Rio de Janeiro, Brazil.
  • Sztajnbok FR; 9 Pediatric Rheumatology Unit, Hospital Jose Alencar, Brasília, Brazil.
  • Paim LB; 10 Pediatric Rheumatology Unit, Pedro Ernesto University Hospital, Rio de Janeiro, Brazil.
  • Barbosa CM; 11 Pediatric Rheumatology Unit, Albert Sabin Children's Hospital, Fortaleza, Brazil.
  • Santos MC; 12 Pediatric Rheumatology Unit, Hospital Darcy Vargas, Sao Paulo, Brazil.
  • Bica BE; 13 Pediatric Rheumatology Unit, Irmandade da Santa Casa de Misericórdia de Sao Paulo, Sao Paulo, Brazil.
  • Sena EG; 14 Rheumatology Division, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil.
  • Moraes AJ; 15 Pediatric Rheumatology Unit, Lauro Vanderley University Hospital, João Pessoa, Brazil.
  • Rolim AM; 16 Pediatric Rheumatology Unit, Federal University of Pará, Belém, Brazil.
  • Spelling PF; 17 Pediatric Rheumatology Unit, Obras Sociais Irmã Dulce, Salvador, Brazil.
  • Scheibel IM; 18 Pediatric Rheumatology Unit, Hospital Evangélico de Curitiba, Curitiba, Brazil.
  • Cavalcanti AS; 19 Pediatric Rheumatology Unit, Hospital Criança Conceição, Porto Alegre, Brazil.
  • Matos EN; 20 Pediatric Rheumatology Unit, Federal University of Pernambuco, Recife, Brazil.
  • Robazzi TC; 21 Pediatric Rheumatology Unit, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.
  • Guimarães LJ; 22 Pediatric Rheumatology Unit, Federal University of Bahia, Salvador, Brazil.
  • Santos FP; 23 Pediatric Rheumatology Unit, University of Brasilia, Brasília, Brazil.
  • Silva CT; 24 Pediatric Rheumatology Unit, Federal University of Minas Gerais, Belo Horizonte, Brazil.
  • Bonfá E; 25 Pediatric Rheumatology Unit, Hospital Municipal Piedade, Rio de Janeiro, Brazil.
  • Silva CA; 3 Division of Rheumatology, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
Lupus ; 27(10): 1712-1717, 2018 Sep.
Article in En | MEDLINE | ID: mdl-30020023
ABSTRACT
Objective The objective of this study was to compare demographic data, clinical/laboratorial features and disease activity at diagnosis in three different groups with distinct time intervals between onset of signs/symptoms and disease diagnosis. Methods A multicenter study was performed in 1555 childhood-onset systemic lupus erythematosus (American College of Rheumatology criteria) patients from 27 pediatric rheumatology services. Patients were divided into three childhood-onset systemic lupus erythematosus groups A short time interval to diagnosis (<1 month); B intermediate time interval (≥1 and <3 months); and C long time interval (≥3 months). An investigator meeting was held to define the protocol. Demographic data, SLICC classification criteria and SLEDAI-2 K were evaluated. Results The number of patients in each group was A = 60 (4%); B = 522 (33.5%); and C = 973 (62.5%). The median age at diagnosis (11.1 (4.2-17) vs. 12 (1.9-17.7) vs. 12.5 (3-18) years, P = 0.025) was significantly lower in group A compared with groups B and C. The median number of diagnostic criteria according to SLICC (7 (4-12) vs. 6 (4-13) vs. 6 (4-12), P < 0.0001) and SLEDAI-2 K (18 (6-57) vs. 16 (2-63) vs. 13 (1-49), P < 0.0001) were significantly higher in group A than the other two groups. The frequency of oral ulcers in the palate (25% vs. 15% vs. 11%, P = 0.003), pleuritis (25% vs. 24% vs. 14%, P < 0.0001), nephritis (52% vs. 47% vs. 40%, P = 0.009), neuropsychiatric manifestations (22% vs. 13% vs. 10%, P = 0.008), thrombocytopenia (32% vs. 18% vs. 19%, P = 0.037), leucopenia/lymphopenia (65% vs. 46% vs. 40%, P < 0.0001) and anti-dsDNA antibodies (79% vs. 66% vs. 61%, P = 0.01) were significantly higher in group A compared with the other groups. In contrast, group C had a less severe disease characterized by higher frequencies of synovitis (61% vs. 66% vs. 71%, P = 0.032) and lower frequencies of serositis (37% vs. 33% vs. 25%, P = 0.002), proteinuria >500 mg/day (48% vs. 45% vs. 36%, P = 0.002) and low complement levels (81% vs. 81% vs. 71%, P < 0.0001) compared with groups A or B. Conclusions Our large Brazilian multicenter study demonstrated that for most childhood-onset systemic lupus erythematosus patients, diagnosis is delayed probably due to mild disease onset. Conversely, the minority has a very short time interval to diagnosis and a presentation with a more severe and active multisystemic condition.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Delayed Diagnosis / Lupus Erythematosus, Systemic Type of study: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Country/Region as subject: America do sul / Brasil Language: En Year: 2018 Type: Article

Full text: 1 Database: MEDLINE Main subject: Delayed Diagnosis / Lupus Erythematosus, Systemic Type of study: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Country/Region as subject: America do sul / Brasil Language: En Year: 2018 Type: Article